GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (NSE:RPGLIFE) » Definitions » EV-to-FCF

RPG Life Sciences (NSE:RPGLIFE) EV-to-FCF : (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RPG Life Sciences's Enterprise Value is ₹36,291 Mil. RPG Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil. Therefore, RPG Life Sciences's EV-to-FCF for today is .

The historical rank and industry rank for RPG Life Sciences's EV-to-FCF or its related term are showing as below:

NSE:RPGLIFE' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 179.72
Current: 140.78

During the past 13 years, the highest EV-to-FCF of RPG Life Sciences was 179.72. The lowest was 0.00. And the median was 0.00.

NSE:RPGLIFE's EV-to-FCF is ranked worse than
87.45% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs NSE:RPGLIFE: 140.78

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), RPG Life Sciences's stock price is ₹2270.40. RPG Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹42.730. Therefore, RPG Life Sciences's PE Ratio (TTM) for today is 53.13.


RPG Life Sciences EV-to-FCF Historical Data

The historical data trend for RPG Life Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences EV-to-FCF Chart

RPG Life Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.40 12.11 21.03 17.97 95.58

RPG Life Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 95.58 - -

Competitive Comparison of RPG Life Sciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RPG Life Sciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's EV-to-FCF falls into.



RPG Life Sciences EV-to-FCF Calculation

RPG Life Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=36291.480/0
=

RPG Life Sciences's current Enterprise Value is ₹36,291 Mil.
RPG Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RPG Life Sciences  (NSE:RPGLIFE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

RPG Life Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2270.40/42.730
=53.13

RPG Life Sciences's share price for today is ₹2270.40.
RPG Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹42.730.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


RPG Life Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


RPG Life Sciences Business Description

Traded in Other Exchanges
Address
463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines